Friday, December 15, 2023 7:38:14 AM
Recent RNXT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 08:10:23 PM
- RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians • GlobeNewswire Inc. • 09/25/2024 12:30:00 PM
- RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer • GlobeNewswire Inc. • 09/19/2024 12:30:00 PM
- RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York • GlobeNewswire Inc. • 08/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:05:17 PM
- RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 09:03:54 PM
- RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist® • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist® • GlobeNewswire Inc. • 07/08/2024 12:30:00 PM
- University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial • GlobeNewswire Inc. • 06/26/2024 12:30:00 PM
- RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships • GlobeNewswire Inc. • 06/10/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:41:02 PM
- RenovoRx CEO Issues Update Letter to Shareholders • Business Wire • 05/30/2024 12:30:00 PM
- Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery • Business Wire • 05/21/2024 01:00:00 PM
- RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024 • Business Wire • 05/14/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/13/2024 04:15:43 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:21:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:50:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:47:08 PM
- RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024 • Business Wire • 05/02/2024 01:00:00 PM
- RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement • Business Wire • 04/18/2024 12:30:00 PM
- RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting • Business Wire • 04/16/2024 12:30:00 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM